Ultrasound Machine Supplier Arrested In Bengaluru

Bengaluru: CID investigation in the gender identification and foeticide racket has taken an interesting turn with the arrest of a biomedical company owner, who had supplied ultrasound scanning machines to the arrested doctors.

The arrested is Lakshman Gowda M, owner of Avishkara Bros Biomedical Pvt Ltd in Mangaluru. Gowda had licence to sell biomedical machines, including ultrasound/imaging under Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, to approved diagnostic centres and hospitals.

During investigation, CID sleuths found that Gowda sold three scanning machines to ayurvedic doctor Mallikarjuna, also one of the accused in the case. Mallikarjuna had supplied the machines to other doctors who were performing foeticide.

“If any doctor or hospital has to procure a scanning machine, permission has to be obtained from the competent authority and details of the biomedical firm from where it is being sourced. Only after the competent authority gives permission can the doctor and biomedical firm go ahead with the sale.

After some time, these hospitals had returned the machines to Gowda for resale. It was during resale that Gowda illegally sold them to Mallikarjun by charging around Rs 1.5 lakh per machine,” sources said.

The third machine was recovered from middleman Siddesh, a resident of Davanagere, on Thursday, who was
arrested by CID.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’